HALO logo
halo search icon
Krystal Biotech, Inc.

US$304.23

Price Change Indicator
2.18 (0.722%)
Krystal Biotech, Inc.
KRYS · NAS

Krystal Biotech, Inc.

Start Trading KRYS for Free

US$304.23

Price Arrow2.18 (0.722%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Balance SheetHALO Capital EfficiencyHALO MomentumHALO Price MomentumHammer Bullish+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Krystal Biotech, Inc. Overview

KRYS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Strong

Garp

Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About KRYS

icon
icon

Telephone

1.412.586.5830

icon

Address

Suite 701, 2100 Wharton Street, Pittsburgh, PA 15203

Description

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

KRYS Price Chart

Key Stats

Market Cap

US$8.90B

PE

36.00

EV/EBITDA

39.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 122.8 - 319.48

Trade Value (12mth)

US$16,507,507.00

1 week

-1.38%

1 month

9.46%

YTD

22.33%

1 year

141.08%

All time high

319.48

Key Fundamentals

EPS 3 yr Growth

-228.90%

EBITDA Margin

43.10%

Operating Cashflow

$201m

Free Cash Flow Return

18.40%

ROIC

18.80%

Interest Coverage

0.00

Quick Ratio

9.60

Other Data

Shares Outstanding (Fully Diluted)

31m

HALO Sector

Healthcare

Next Company Report Date

01-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

KRYS Announcements

Latest Announcements

DateAnnouncements
20 May 26
20 May 26
04 May 26
04 May 26
04 May 26

KRYS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.43.127.08locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.3936.84locklocklock
Growth
 %locklocklocklock107.3674.5126.9locklocklock
PE
 Xlocklocklocklock31552.336locklocklock
EV/EBITDA
 XlocklocklocklockN/A36.939.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Krystal Biotech, Inc. (KRYS:NAS)?
Halo FAQ
The current share price of Krystal Biotech, Inc. (KRYS:NAS) is USD$304.23.
What is the 52-week high share price for Krystal Biotech, Inc. (KRYS:NAS)?
Halo FAQ
The 52-week high share price for Krystal Biotech, Inc. (KRYS:NAS) is USD$319.48.
What is the 52-week low share price for Krystal Biotech, Inc. (KRYS:NAS)?
Halo FAQ
The 52-week low share price for Krystal Biotech, Inc. (KRYS:NAS) is USD$122.80.
What is the dividend yield for Krystal Biotech, Inc. (KRYS:NAS)?
Halo FAQ
Krystal Biotech, Inc. (KRYS:NAS) does not pay a dividend.
What was Krystal Biotech, Inc. (KRYS:NAS) last dividend payment?
Halo FAQ
Krystal Biotech, Inc. (KRYS:NAS) does not pay a dividend.
What is the franking level for Krystal Biotech, Inc. (KRYS:NAS)?
Halo FAQ
Krystal Biotech, Inc. (KRYS:NAS) has a franking level of 0.00%.
In which sector is Krystal Biotech, Inc. (KRYS:NAS) classified?
Halo FAQ
Krystal Biotech, Inc. (KRYS:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Krystal Biotech, Inc. (KRYS:NAS)?
Halo FAQ
The current P/E ratio for Krystal Biotech, Inc. (KRYS:NAS) is 36.00.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial